{"transactions":[{"id":4625569,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-23T20:59:17.000Z","date":"2026-09-23","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":100,"value":500000.0,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon Faiz Kayyem and Paige N. Gates Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":434360,"source":{"system":"sec-edgar","filing":"0001366268-26-000011","document":"wk-form4_1790197155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007919/000136626826000011/wk-form4_1790197155.xml","form_type":"4"}},{"id":4622888,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-09-18T20:20:29.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will be fully exercisable on June 3, 2027, subject to the reporting person's continued service through such date."}],"balance_after":10000,"derivative":{"exercise_price":95.22,"exercise_date":"2027-06-03","expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001366268-26-000009","document":"wk-form4a_1789762826.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007919/000136626826000009/wk-form4a_1789762826.xml","form_type":"4/A","original_submission_date":"2026-06-04"}},{"id":4621820,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-17T21:46:50.000Z","date":"2026-09-16","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":100,"value":500000.0,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon Faiz Kayyem and Paige N. Gates Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":429360,"source":{"system":"sec-edgar","filing":"0001366268-26-000006","document":"wk-form4_1789681608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007919/000136626826000006/wk-form4_1789681608.xml","form_type":"4"}},{"id":3552287,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-08T21:23:30.000Z","date":"2026-09-08","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":113.516,"value":567580.0,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple transactions at prices ranging from $113.30 to $113.55 inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon Faiz Kayyem and Paige N. Gates Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":424360,"source":{"system":"sec-edgar","filing":"0001366268-26-000004","document":"wk-form4_1788902607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007919/000136626826000004/wk-form4_1788902607.xml","form_type":"4"}},{"id":749321,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-04T21:29:06.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will be fully exercisable on June 3, 2027, subject to the reporting person's continued service through such date."}],"balance_after":15000,"derivative":{"exercise_price":95.22,"exercise_date":"2027-06-03","expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001366268-26-000002","document":"wk-form4_1780608544.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000136626826000002/wk-form4_1780608544.xml","form_type":"4"}},{"id":946302,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-06T21:25:57.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":6354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer."}],"balance_after":6354,"derivative":{"exercise_price":6.46,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":6354},"source":{"system":"sec-edgar","filing":"0000905148-26-000069","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000069/form4.xml","form_type":"4"}},{"id":946301,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-01-06T21:25:57.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":5443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":5443,"derivative":{"underlying":"Common Stock","underlying_shares":5443},"source":{"system":"sec-edgar","filing":"0000905148-26-000069","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000069/form4.xml","form_type":"4"}},{"id":1130343,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-29T20:27:56.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will be fully exercisable on May 28, 2026, subject to the reporting person's continued service through such date."}],"balance_after":15000,"derivative":{"exercise_price":12.91,"exercise_date":"2026-05-28","expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0002007919-25-000068","document":"wk-form4_1748550471.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000200791925000068/wk-form4_1748550471.xml","form_type":"4"}},{"id":1136968,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2025-05-22T20:14:40.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":42010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer."}],"balance_after":42010,"derivative":{"exercise_price":0.2708,"expiration_date":"2035-05-19","underlying":"Common Stock","underlying_shares":42010},"source":{"system":"sec-edgar","filing":"0000905148-25-001893","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825001893/form4.xml","form_type":"4"}},{"id":1136967,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-05-22T20:14:40.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":68621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":68621,"derivative":{"underlying":"Common Stock","underlying_shares":68621},"source":{"system":"sec-edgar","filing":"0000905148-25-001893","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825001893/form4.xml","form_type":"4"}},{"id":1188700,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-28T21:37:18.000Z","date":"2025-03-27","kind":"gift","planned":false,"acquired":false,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of 90,000 shares of Common Stock by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust to the reporting person's adult children not residing in the reporting person's household, and to which the reporting person does not have a beneficial interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon Faiz Kayyem and Paige N. Gates Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":419360,"source":{"system":"sec-edgar","filing":"0002007919-25-000025","document":"wk-form4_1743197832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000200791925000025/wk-form4_1743197832.xml","form_type":"4"}},{"id":1328252,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-17T21:29:56.000Z","date":"2024-12-16","kind":"gift","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Paige Gates-Kayyem Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the transfer for no consideration of shares of Common Stock from The Jon F. Kayyem and Paige Gates-Kayyem Family Trust to the Jon Faiz Kayyem Revocable Trust and the Paige-Gates Kayyem Revocable Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are directly owned by the Paige-Gates Kayyem Revocable Trust, of which Jon Faiz Kayyem's spouse is the trustee."}],"balance_after":250000,"source":{"system":"sec-edgar","filing":"0002007919-24-000068","document":"wk-form4_1734470990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000200791924000068/wk-form4_1734470990.xml","form_type":"4"}},{"id":1328251,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-17T21:29:56.000Z","date":"2024-12-16","kind":"gift","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Jon Faiz Kayyem Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the transfer for no consideration of shares of Common Stock from The Jon F. Kayyem and Paige Gates-Kayyem Family Trust to the Jon Faiz Kayyem Revocable Trust and the Paige-Gates Kayyem Revocable Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are directly owned by the Jon Faiz Kayyem Revocable Trust, of which Jon Faiz Kayyem is the trustee."}],"balance_after":250000,"source":{"system":"sec-edgar","filing":"0002007919-24-000068","document":"wk-form4_1734470990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000200791924000068/wk-form4_1734470990.xml","form_type":"4"}},{"id":1328250,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-17T21:29:56.000Z","date":"2024-12-16","kind":"gift","planned":false,"acquired":false,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the transfer for no consideration of shares of Common Stock from The Jon F. Kayyem and Paige Gates-Kayyem Family Trust to the Jon Faiz Kayyem Revocable Trust and the Paige-Gates Kayyem Revocable Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon Faiz Kayyem and Paige N. Gates Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":509360,"source":{"system":"sec-edgar","filing":"0002007919-24-000068","document":"wk-form4_1734470990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000200791924000068/wk-form4_1734470990.xml","form_type":"4"}},{"id":1340220,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-06T21:51:12.000Z","date":"2024-12-06","kind":"gift","planned":false,"acquired":false,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of 52,000 shares of Common Stock by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust to the reporting person's adult children not residing in the reporting person's household, and to which the reporting person does not have a beneficial interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon Faiz Kayyem and Paige N. Gates Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":1009360,"source":{"system":"sec-edgar","filing":"0002007919-24-000066","document":"wk-form4_1733521865.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000200791924000066/wk-form4_1733521865.xml","form_type":"4"}},{"id":1353909,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-22T21:03:55.000Z","date":"2024-11-20","kind":"purchase","planned":false,"acquired":true,"shares":18750,"price":14.1921,"value":266101.875,"ownership":{"direct":false,"nature":"By Child B"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The shares were purchased in multiple transactions at prices ranging from $13.93 to $14.25, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are directly owned by a custodial account managed by the reporting person for the benefit of the reporting person's minor child, Child B. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":69843,"source":{"system":"sec-edgar","filing":"0002007919-24-000064","document":"wk-form4_1732309427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000200791924000064/wk-form4_1732309427.xml","form_type":"4"}},{"id":1353908,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-22T21:03:55.000Z","date":"2024-11-20","kind":"purchase","planned":false,"acquired":true,"shares":18750,"price":14.1921,"value":266101.875,"ownership":{"direct":false,"nature":"By Child A"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The shares were purchased in multiple transactions at prices ranging from $13.93 to $14.25, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are directly owned by a custodial account managed by the reporting person for the benefit of the reporting person's minor child, Child A. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":69843,"source":{"system":"sec-edgar","filing":"0002007919-24-000064","document":"wk-form4_1732309427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000200791924000064/wk-form4_1732309427.xml","form_type":"4"}},{"id":1353907,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-22T21:03:55.000Z","date":"2024-11-19","kind":"purchase","planned":false,"acquired":true,"shares":34843,"price":14.2269,"value":495707.8767,"ownership":{"direct":false,"nature":"By Child B"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The shares were purchased in multiple transactions at prices ranging from $14.09 to $14.25, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are directly owned by a custodial account managed by the reporting person for the benefit of the reporting person's minor child, Child B. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":51093,"source":{"system":"sec-edgar","filing":"0002007919-24-000064","document":"wk-form4_1732309427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000200791924000064/wk-form4_1732309427.xml","form_type":"4"}},{"id":1353906,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-22T21:03:55.000Z","date":"2024-11-19","kind":"purchase","planned":false,"acquired":true,"shares":34843,"price":14.2269,"value":495707.8767,"ownership":{"direct":false,"nature":"By Child A"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The shares were purchased in multiple transactions at prices ranging from $14.09 to $14.25, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are directly owned by a custodial account managed by the reporting person for the benefit of the reporting person's minor child, Child A. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":51093,"source":{"system":"sec-edgar","filing":"0002007919-24-000064","document":"wk-form4_1732309427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000200791924000064/wk-form4_1732309427.xml","form_type":"4"}},{"id":1470450,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-24T21:27:15.000Z","date":"2024-06-24","kind":"gift","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Child B"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction involved a gift of 10,000 shares of Common Stock by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust to a custodial account managed by the reporting person for the benefit of the\nreporting person's minor child, Child B. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":16250,"source":{"system":"sec-edgar","filing":"0002007919-24-000024","document":"wk-form4_1719264429.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000200791924000024/wk-form4_1719264429.xml","form_type":"4"}},{"id":1470449,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-24T21:27:15.000Z","date":"2024-06-24","kind":"gift","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Child A"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction involved a gift of 10,000 shares of Common Stock by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust to a custodial account managed by the reporting person for the benefit of the\nreporting person's minor child, Child A. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":16250,"source":{"system":"sec-edgar","filing":"0002007919-24-000024","document":"wk-form4_1719264429.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000200791924000024/wk-form4_1719264429.xml","form_type":"4"}},{"id":1470448,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-24T21:27:15.000Z","date":"2024-06-24","kind":"gift","planned":false,"acquired":false,"shares":89050,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of 89,050 shares of Common Stock by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust to the reporting person's children, relatives, and other individuals. Of the shares gifted, 40,000 shares were gifted to the reporting person's adult children not residing in the reporting person's household, 22,825 shares were gifted to trusts for the benefit of individuals not residing in the reporting person's household, 4,150 shares were gifted to relatives not residing in the reporting person's household, and 2,075 shares were gifted to a UTMA for the benefit of a minor not residing in the reporting person's household, in each case to which the reporting person does not have a beneficial interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon Faiz Kayyem and Paige N. Gates Family Trust and he disclaims\nbeneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":1061360,"source":{"system":"sec-edgar","filing":"0002007919-24-000024","document":"wk-form4_1719264429.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000200791924000024/wk-form4_1719264429.xml","form_type":"4"}},{"id":1486310,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T22:05:13.000Z","date":"2024-06-05","kind":"purchase","planned":false,"acquired":true,"shares":8265,"price":17.89,"value":147860.85,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were purchased in multiple transactions at prices ranging from $17.81 to $18.10, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":1150410,"source":{"system":"sec-edgar","filing":"0002007919-24-000008","document":"wk-form4_1717797906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000200791924000008/wk-form4_1717797906.xml","form_type":"4"}},{"id":1486309,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T22:05:13.000Z","date":"2024-06-05","kind":"purchase","planned":false,"acquired":true,"shares":49284,"price":17.23,"value":849163.32,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple transactions at prices ranging from $16.81 to $17.805, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":1142145,"source":{"system":"sec-edgar","filing":"0002007919-24-000008","document":"wk-form4_1717797906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000200791924000008/wk-form4_1717797906.xml","form_type":"4"}},{"id":1491626,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T21:27:32.000Z","date":"2024-06-04","kind":"purchase","planned":false,"acquired":true,"shares":23726,"price":18.24,"value":432762.24,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares were purchased in multiple transactions at prices ranging from $18.01 to $18.50, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":1092861,"source":{"system":"sec-edgar","filing":"0002007919-24-000006","document":"wk-form4_1717536444.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000200791924000006/wk-form4_1717536444.xml","form_type":"4"}},{"id":1491625,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T21:27:32.000Z","date":"2024-06-04","kind":"purchase","planned":false,"acquired":true,"shares":65337,"price":17.44,"value":1139477.28,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were purchased in multiple transactions at prices ranging from $17.01 to $18.00, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":1069135,"source":{"system":"sec-edgar","filing":"0002007919-24-000006","document":"wk-form4_1717536444.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000200791924000006/wk-form4_1717536444.xml","form_type":"4"}},{"id":1491624,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T21:27:32.000Z","date":"2024-06-03","kind":"purchase","planned":false,"acquired":true,"shares":80738,"price":17.9,"value":1445210.2,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were purchased in multiple transactions at prices ranging from $17.40 to $18.10, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":1003798,"source":{"system":"sec-edgar","filing":"0002007919-24-000006","document":"wk-form4_1717536444.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000200791924000006/wk-form4_1717536444.xml","form_type":"4"}},{"id":1491623,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T21:27:32.000Z","date":"2024-06-03","kind":"purchase","planned":false,"acquired":true,"shares":46792,"price":16.61,"value":777215.12,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were purchased in multiple transactions at prices ranging from $16.25 to $16.75, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":923060,"source":{"system":"sec-edgar","filing":"0002007919-24-000006","document":"wk-form4_1717536444.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000200791924000006/wk-form4_1717536444.xml","form_type":"4"}},{"id":1491622,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T21:27:32.000Z","date":"2024-05-31","kind":"purchase","planned":false,"acquired":true,"shares":70193,"price":16.14,"value":1132915.02,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple transactions at prices ranging from $15.75 to $16.25, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":876268,"source":{"system":"sec-edgar","filing":"0002007919-24-000006","document":"wk-form4_1717536444.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000200791924000006/wk-form4_1717536444.xml","form_type":"4"}},{"id":1497601,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T22:22:37.000Z","date":"2024-05-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under the Agreement and Plan of Merger, dated January 22, 2024 (the \"Merger Agreement\"), by and among the Inhibrx, Inc. (the \"Issuer\"), Aventis Inc., a Pennsylvania corporation (\"Parent\") and wholly owned subsidiary of Sanofi, and Art Acquisition Sub, Inc., a Delaware corporation (\"Merger Sub\") and wholly owned subsidiary of Parent, following satisfaction or waiver of the closing conditions set forth in the Merger Agreement, on May 30, 2024, Merger Sub merged with and into the Issuer with the Issuer surviving as the surviving company (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This stock option was cancelled in the Merger and converted into the right to receive (A) an amount in cash, without interest and less any applicable withholding taxes, equal to the product of (x) the total number of shares of the Issuer's common stock subject to such stock options immediately prior to the Effective Time, multiplied by (y) the excess of (I) the Closing Amount over (II) the exercise price payable per share of the Issuer common stock under such option and (B) one (1) CVR for each share of the Issuer common stock subject to such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on June 7, 2022, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":0,"derivative":{"exercise_price":24.78,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950142-24-001499","document":"es240484809_4-kayyem.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000095014224001499/es240484809_4-kayyem.xml","form_type":"4"}},{"id":1497600,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T22:22:37.000Z","date":"2024-05-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under the Agreement and Plan of Merger, dated January 22, 2024 (the \"Merger Agreement\"), by and among the Inhibrx, Inc. (the \"Issuer\"), Aventis Inc., a Pennsylvania corporation (\"Parent\") and wholly owned subsidiary of Sanofi, and Art Acquisition Sub, Inc., a Delaware corporation (\"Merger Sub\") and wholly owned subsidiary of Parent, following satisfaction or waiver of the closing conditions set forth in the Merger Agreement, on May 30, 2024, Merger Sub merged with and into the Issuer with the Issuer surviving as the surviving company (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This stock option was cancelled in the Merger and converted into the right to receive (A) an amount in cash, without interest and less any applicable withholding taxes, equal to the product of (x) the total number of shares of the Issuer's common stock subject to such stock options immediately prior to the Effective Time, multiplied by (y) the excess of (I) the Closing Amount over (II) the exercise price payable per share of the Issuer common stock under such option and (B) one (1) CVR for each share of the Issuer common stock subject to such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on May 25, 2023, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":0,"derivative":{"exercise_price":12.57,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950142-24-001499","document":"es240484809_4-kayyem.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000095014224001499/es240484809_4-kayyem.xml","form_type":"4"}},{"id":1497599,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T22:22:37.000Z","date":"2024-05-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under the Agreement and Plan of Merger, dated January 22, 2024 (the \"Merger Agreement\"), by and among the Inhibrx, Inc. (the \"Issuer\"), Aventis Inc., a Pennsylvania corporation (\"Parent\") and wholly owned subsidiary of Sanofi, and Art Acquisition Sub, Inc., a Delaware corporation (\"Merger Sub\") and wholly owned subsidiary of Parent, following satisfaction or waiver of the closing conditions set forth in the Merger Agreement, on May 30, 2024, Merger Sub merged with and into the Issuer with the Issuer surviving as the surviving company (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This stock option was cancelled in the Merger and converted into the right to receive (A) an amount in cash, without interest and less any applicable withholding taxes, equal to the product of (x) the total number of shares of the Issuer's common stock subject to such stock options immediately prior to the Effective Time, multiplied by (y) the excess of (I) the Closing Amount over (II) the exercise price payable per share of the Issuer common stock under such option and (B) one (1) CVR for each share of the Issuer common stock subject to such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on May 25, 2024, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":0,"derivative":{"exercise_price":23.03,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950142-24-001499","document":"es240484809_4-kayyem.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000095014224001499/es240484809_4-kayyem.xml","form_type":"4"}},{"id":1497598,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T22:22:37.000Z","date":"2024-05-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17259,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under the Agreement and Plan of Merger, dated January 22, 2024 (the \"Merger Agreement\"), by and among the Inhibrx, Inc. (the \"Issuer\"), Aventis Inc., a Pennsylvania corporation (\"Parent\") and wholly owned subsidiary of Sanofi, and Art Acquisition Sub, Inc., a Delaware corporation (\"Merger Sub\") and wholly owned subsidiary of Parent, following satisfaction or waiver of the closing conditions set forth in the Merger Agreement, on May 30, 2024, Merger Sub merged with and into the Issuer with the Issuer surviving as the surviving company (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This stock option was cancelled in the Merger and converted into the right to receive (A) an amount in cash, without interest and less any applicable withholding taxes, equal to the product of (x) the total number of shares of the Issuer's common stock subject to such stock options immediately prior to the Effective Time, multiplied by (y) the excess of (I) the Closing Amount over (II) the exercise price payable per share of the Issuer common stock under such option and (B) one (1) CVR for each share of the Issuer common stock subject to such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on November 26, 2019, with the balance having vested and have become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":0,"derivative":{"exercise_price":10.52,"expiration_date":"2028-11-26","underlying":"Common Stock","underlying_shares":17259},"source":{"system":"sec-edgar","filing":"0000950142-24-001499","document":"es240484809_4-kayyem.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000095014224001499/es240484809_4-kayyem.xml","form_type":"4"}},{"id":1497597,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T22:22:37.000Z","date":"2024-05-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"price":30,"value":750000.0,"ownership":{"direct":false,"nature":"By Child B"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under the Agreement and Plan of Merger, dated January 22, 2024 (the \"Merger Agreement\"), by and among the Inhibrx, Inc. (the \"Issuer\"), Aventis Inc., a Pennsylvania corporation (\"Parent\") and wholly owned subsidiary of Sanofi, and Art Acquisition Sub, Inc., a Delaware corporation (\"Merger Sub\") and wholly owned subsidiary of Parent, following satisfaction or waiver of the closing conditions set forth in the Merger Agreement, on May 30, 2024, Merger Sub merged with and into the Issuer with the Issuer surviving as the surviving company (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In the Merger, each share of common stock of the Issuer that was outstanding immediately prior to the effective time of the Merger (the \"Effective Time\") (other than (A) the Issuer's common stock owned by the Issuer as treasury shares, (B) the Issuer's common stock owned by Parent or Merger Sub and (C) any dissenting shares), was automatically cancelled, extinguished and converted into the right to receive (i) an amount in cash equal to $30.00, without interest thereon (the \"Closing Amount\"), plus (ii) one (1) contractual contingent value right (\"CVR\") representing the right to receive a contingent payment of $5.00, without interest thereon, in cash (the \"Milestone Payment\"), upon the achievement of certain regulatory milestones (\"Milestone\") set forth in the Contingent Value Rights Agreement between Parent and Continental Stock Transfer & Trust Company."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities were held in a custodial account managed by the reporting person for the benefit of the reporting person's minor child, Child B. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950142-24-001499","document":"es240484809_4-kayyem.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000095014224001499/es240484809_4-kayyem.xml","form_type":"4"}},{"id":1497596,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T22:22:37.000Z","date":"2024-05-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"price":30,"value":750000.0,"ownership":{"direct":false,"nature":"By Child A"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under the Agreement and Plan of Merger, dated January 22, 2024 (the \"Merger Agreement\"), by and among the Inhibrx, Inc. (the \"Issuer\"), Aventis Inc., a Pennsylvania corporation (\"Parent\") and wholly owned subsidiary of Sanofi, and Art Acquisition Sub, Inc., a Delaware corporation (\"Merger Sub\") and wholly owned subsidiary of Parent, following satisfaction or waiver of the closing conditions set forth in the Merger Agreement, on May 30, 2024, Merger Sub merged with and into the Issuer with the Issuer surviving as the surviving company (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In the Merger, each share of common stock of the Issuer that was outstanding immediately prior to the effective time of the Merger (the \"Effective Time\") (other than (A) the Issuer's common stock owned by the Issuer as treasury shares, (B) the Issuer's common stock owned by Parent or Merger Sub and (C) any dissenting shares), was automatically cancelled, extinguished and converted into the right to receive (i) an amount in cash equal to $30.00, without interest thereon (the \"Closing Amount\"), plus (ii) one (1) contractual contingent value right (\"CVR\") representing the right to receive a contingent payment of $5.00, without interest thereon, in cash (the \"Milestone Payment\"), upon the achievement of certain regulatory milestones (\"Milestone\") set forth in the Contingent Value Rights Agreement between Parent and Continental Stock Transfer & Trust Company."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities were held in a custodial account managed by the reporting person for the benefit of the reporting person's minor child, Child A. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950142-24-001499","document":"es240484809_4-kayyem.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000095014224001499/es240484809_4-kayyem.xml","form_type":"4"}},{"id":1497595,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T22:22:37.000Z","date":"2024-05-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3224301,"price":30,"value":96729030.0,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under the Agreement and Plan of Merger, dated January 22, 2024 (the \"Merger Agreement\"), by and among the Inhibrx, Inc. (the \"Issuer\"), Aventis Inc., a Pennsylvania corporation (\"Parent\") and wholly owned subsidiary of Sanofi, and Art Acquisition Sub, Inc., a Delaware corporation (\"Merger Sub\") and wholly owned subsidiary of Parent, following satisfaction or waiver of the closing conditions set forth in the Merger Agreement, on May 30, 2024, Merger Sub merged with and into the Issuer with the Issuer surviving as the surviving company (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In the Merger, each share of common stock of the Issuer that was outstanding immediately prior to the effective time of the Merger (the \"Effective Time\") (other than (A) the Issuer's common stock owned by the Issuer as treasury shares, (B) the Issuer's common stock owned by Parent or Merger Sub and (C) any dissenting shares), was automatically cancelled, extinguished and converted into the right to receive (i) an amount in cash equal to $30.00, without interest thereon (the \"Closing Amount\"), plus (ii) one (1) contractual contingent value right (\"CVR\") representing the right to receive a contingent payment of $5.00, without interest thereon, in cash (the \"Milestone Payment\"), upon the achievement of certain regulatory milestones (\"Milestone\") set forth in the Contingent Value Rights Agreement between Parent and Continental Stock Transfer & Trust Company."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities were directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon F. Kayyem and Paige Gates-Kayyem Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950142-24-001499","document":"es240484809_4-kayyem.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000095014224001499/es240484809_4-kayyem.xml","form_type":"4"}},{"id":1497594,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T22:10:31.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F5","text":"This stock option was granted following the consummation of the merger of Inhibrx, Inc. with a wholly owned indirect subsidiary of Sanofi."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This stock option will be fully exercisable on May 30, 2025, subject to the reporting person?s continued service through such date."}],"balance_after":30000,"derivative":{"exercise_price":15.86,"expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950142-24-001492","document":"es240484862_4-kayyem.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000095014224001492/es240484862_4-kayyem.xml","form_type":"4"}},{"id":1497593,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T22:10:31.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":6250,"ownership":{"direct":false,"nature":"By Child B"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transactions reported herein are the result of the consummation on May 29, 2024 of the distribution by Inhibrx, Inc. of 92% of the issued and outstanding shares of common stock of its subsidiary, Inhibrx Biosciences, Inc. (the \"Issuer\"), to holders of shares of Inhibrx, Inc.'s common stock as of the distribution record date of May 17, 2024, on a pro rata basis, at a ratio of one share of the Company's common stock for every four shares of Inhibrx, Inc.'s issued and outstanding common stock held on the distribution record date. These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are held in a custodial account managed by the reporting person for the benefit of the reporting person's minor child, Child B. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":6250,"source":{"system":"sec-edgar","filing":"0000950142-24-001492","document":"es240484862_4-kayyem.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000095014224001492/es240484862_4-kayyem.xml","form_type":"4"}},{"id":1497592,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T22:10:31.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":6250,"ownership":{"direct":false,"nature":"By Child A"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transactions reported herein are the result of the consummation on May 29, 2024 of the distribution by Inhibrx, Inc. of 92% of the issued and outstanding shares of common stock of its subsidiary, Inhibrx Biosciences, Inc. (the \"Issuer\"), to holders of shares of Inhibrx, Inc.'s common stock as of the distribution record date of May 17, 2024, on a pro rata basis, at a ratio of one share of the Company's common stock for every four shares of Inhibrx, Inc.'s issued and outstanding common stock held on the distribution record date. These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held in a custodial account managed by the reporting person for the benefit of the reporting person's minor child, Child A. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":6250,"source":{"system":"sec-edgar","filing":"0000950142-24-001492","document":"es240484862_4-kayyem.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000095014224001492/es240484862_4-kayyem.xml","form_type":"4"}},{"id":1497591,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T22:10:31.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":806075,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transactions reported herein are the result of the consummation on May 29, 2024 of the distribution by Inhibrx, Inc. of 92% of the issued and outstanding shares of common stock of its subsidiary, Inhibrx Biosciences, Inc. (the \"Issuer\"), to holders of shares of Inhibrx, Inc.'s common stock as of the distribution record date of May 17, 2024, on a pro rata basis, at a ratio of one share of the Company's common stock for every four shares of Inhibrx, Inc.'s issued and outstanding common stock held on the distribution record date. These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon F. Kayyem and Paige Gates-Kayyem Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":806075,"source":{"system":"sec-edgar","filing":"0000950142-24-001492","document":"es240484862_4-kayyem.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000095014224001492/es240484862_4-kayyem.xml","form_type":"4"}},{"id":1503552,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2024-05-23T23:13:45.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":37050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, this option will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."}],"balance_after":37050,"derivative":{"exercise_price":1.57,"expiration_date":"2034-05-20","underlying":"Common Stock","underlying_shares":37050},"source":{"system":"sec-edgar","filing":"0000905148-24-001609","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001609/form4.xml","form_type":"4"}},{"id":1503551,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-05-23T23:13:45.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":46686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":46686,"derivative":{"underlying":"Common Stock","underlying_shares":46686},"source":{"system":"sec-edgar","filing":"0000905148-24-001609","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001609/form4.xml","form_type":"4"}},{"id":1692038,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-01-03T21:15:21.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":105389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":134262,"derivative":{"underlying":"Common Stock","underlying_shares":105389},"source":{"system":"sec-edgar","filing":"0000905148-24-000040","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824000040/form4.xml","form_type":"4"}},{"id":1813773,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-07T21:30:04.000Z","date":"2023-08-03","kind":"grant","planned":false,"acquired":true,"shares":6172,"price":1.62,"value":9998.64,"ownership":{"direct":false,"nature":"By The Jon Faiz Kayyem Revocable Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are directly owned by The Jon Faiz Kayyem Revocable Trust, of which Jon Faiz Kayyem and his spouse serve as co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":180085,"source":{"system":"sec-edgar","filing":"0000905148-23-000622","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823000622/form4.xml","form_type":"4"}},{"id":1874424,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-30T20:07:19.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on May 25, 2024, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":15000,"derivative":{"exercise_price":23.03,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001739614-23-000050","document":"wk-form4_1685477228.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000173961423000050/wk-form4_1685477228.xml","form_type":"4"}},{"id":1877968,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-05-25T22:21:54.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":28873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."}],"balance_after":28873,"derivative":{"underlying":"Common Stock","underlying_shares":28873},"source":{"system":"sec-edgar","filing":"0001140361-23-026718","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123026718/form4.xml","form_type":"4"}},{"id":1927855,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-04-04T20:36:18.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":false,"shares":145833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs vested in full on March 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These RSUs vested in full on March 31, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This amount includes 4,878 deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer."}],"balance_after":4878,"derivative":{"underlying":"Common Stock","underlying_shares":145833},"source":{"system":"sec-edgar","filing":"0001140361-23-016261","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123016261/form4.xml","form_type":"4"}},{"id":1927854,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-04T20:36:18.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":true,"shares":145833,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":177452,"source":{"system":"sec-edgar","filing":"0001140361-23-016261","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123016261/form4.xml","form_type":"4"}},{"id":2048496,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-23T23:10:31.000Z","date":"2023-01-23","kind":"sale","acquired":false,"shares":9500,"price":25.2631,"value":239999.45,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $25.00 to $25.61, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon F. Kayyem and Paige Gates-Kayyem Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":3224301,"source":{"system":"sec-edgar","filing":"0001739614-23-000008","document":"wf-form4_167451541190833.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000173961423000008/wf-form4_167451541190833.xml","form_type":"4"}},{"id":2062435,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-01-05T21:31:04.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":4878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 4,878 deferred RSUs.  The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer."}],"balance_after":150711,"derivative":{"underlying":"Common Stock","underlying_shares":4878},"source":{"system":"sec-edgar","filing":"0001140361-23-000668","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123000668/form4.xml","form_type":"4"}},{"id":2067062,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-01-04T23:20:58.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."}],"balance_after":145833,"derivative":{"underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001140361-23-000519","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123000519/form4.xml","form_type":"4"}},{"id":2077580,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-12-22T21:31:04.000Z","date":"2022-12-21","kind":"exercise","acquired":false,"shares":31619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units vested in full on December 5, 2022 and were settled in shares of Common Stock on December 21, 2022. These restricted stock units had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units vested in full on December 5, 2022 and were settled in shares of Common Stock on December 21, 2022. These restricted stock units had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":31619},"source":{"system":"sec-edgar","filing":"0001140361-22-046669","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122046669/form4.xml","form_type":"4"}},{"id":2077579,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-12-22T21:31:04.000Z","date":"2022-12-21","kind":"exercise","acquired":true,"shares":31619,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."}],"balance_after":31619,"source":{"system":"sec-edgar","filing":"0001140361-22-046669","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122046669/form4.xml","form_type":"4"}},{"id":2077463,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-22T21:04:29.000Z","date":"2022-12-21","kind":"sale","acquired":false,"shares":1959,"price":27.6099,"value":54087.7941,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in multiple transactions at prices ranging from $27.39 to $27.74, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon F. Kayyem and Paige Gates-Kayyem Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":3233801,"source":{"system":"sec-edgar","filing":"0001739614-22-000132","document":"wf-form4_167174304358342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000173961422000132/wf-form4_167174304358342.xml","form_type":"4"}},{"id":2077462,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-22T21:04:29.000Z","date":"2022-12-21","kind":"sale","acquired":false,"shares":7541,"price":26.8653,"value":202591.2273,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $26.385 to $27.38, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon F. Kayyem and Paige Gates-Kayyem Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":3235760,"source":{"system":"sec-edgar","filing":"0001739614-22-000132","document":"wf-form4_167174304358342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000173961422000132/wf-form4_167174304358342.xml","form_type":"4"}},{"id":2106655,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-22T21:42:44.000Z","date":"2022-11-21","kind":"sale","acquired":false,"shares":6767,"price":30.1196,"value":203819.3332,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in multiple transactions at prices ranging from $29.77 to $30.5115, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon F. Kayyem and Paige Gates-Kayyem Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":3243301,"source":{"system":"sec-edgar","filing":"0001739614-22-000126","document":"wf-form4_166915334652304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000173961422000126/wf-form4_166915334652304.xml","form_type":"4"}},{"id":2106654,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-22T21:42:44.000Z","date":"2022-11-21","kind":"sale","acquired":false,"shares":2733,"price":29.3279,"value":80153.1507,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $28.77 to $29.7697, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon F. Kayyem and Paige Gates-Kayyem Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":3250068,"source":{"system":"sec-edgar","filing":"0001739614-22-000126","document":"wf-form4_166915334652304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000173961422000126/wf-form4_166915334652304.xml","form_type":"4"}},{"id":2108483,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-11-21T23:02:43.000Z","date":"2022-11-21","kind":"purchase","acquired":true,"shares":173913,"price":1.15,"value":199999.95,"ownership":{"direct":false,"nature":"By The Jon Faiz Kayyem Revocable Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are directly owned by The Jon Faiz Kayyem Revocable Trust, of which Jon Faiz Kayyem and his spouse serve as co-trustees.  The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":173913,"source":{"system":"sec-edgar","filing":"0001140361-22-042596","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122042596/form4.xml","form_type":"4"}},{"id":2132822,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-24T20:36:46.000Z","date":"2022-10-21","kind":"sale","acquired":false,"shares":5928,"price":30.576,"value":181254.528,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in multiple transactions at prices ranging from $30.34 to $31.00, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon F. Kayyem and Paige Gates-Kayyem Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":3252801,"source":{"system":"sec-edgar","filing":"0001739614-22-000109","document":"wf-form4_166664378588834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000173961422000109/wf-form4_166664378588834.xml","form_type":"4"}},{"id":2132821,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-24T20:36:46.000Z","date":"2022-10-21","kind":"sale","acquired":false,"shares":3572,"price":29.3889,"value":104977.1508,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $29.14 to $29.96, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon F. Kayyem and Paige Gates-Kayyem Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":3258729,"source":{"system":"sec-edgar","filing":"0001739614-22-000109","document":"wf-form4_166664378588834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000173961422000109/wf-form4_166664378588834.xml","form_type":"4"}},{"id":2173761,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-25T20:20:41.000Z","date":"2022-08-24","kind":"gift","acquired":false,"shares":11900,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of 11,900 shares of Common Stock by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust to a trust for the benefit of individuals not residing in the reporting person's household, to which the reporting person does not have a beneficial interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon F. Kayyem and Paige Gates-Kayyem Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":3262301,"source":{"system":"sec-edgar","filing":"0001739614-22-000093","document":"wf-form4_166145880183931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000173961422000093/wf-form4_166145880183931.xml","form_type":"4"}},{"id":2191758,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-08T20:22:01.000Z","date":"2022-08-05","kind":"gift","acquired":false,"shares":3400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of 3,400 shares of Common Stock by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Of the shares gifted, 1,400 shares were gifted to individuals not residing in the reporting person's household, and 2,000 shares were gifted to a trust for the benefit of individuals not residing in the reporting person's household, in each case to which the reporting person does not have a beneficial interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon F. Kayyem and Paige Gates-Kayyem Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":3274201,"source":{"system":"sec-edgar","filing":"0001739614-22-000086","document":"wf-form4_165999008770441.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000173961422000086/wf-form4_165999008770441.xml","form_type":"4"}},{"id":2197265,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T20:52:22.000Z","date":"2022-08-02","kind":"gift","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Child B"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction involved a gift of 25,000 shares of Common Stock by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust to a custodial account managed by the reporting person for the benefit of the reporting person's minor child, Child B. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001739614-22-000075","document":"wf-form4_165947352645392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000173961422000075/wf-form4_165947352645392.xml","form_type":"4"}},{"id":2197264,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T20:52:22.000Z","date":"2022-08-02","kind":"gift","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Child A"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction involved a gift of 25,000 shares of Common Stock by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust to a custodial account managed by the reporting person for the benefit of the reporting person's minor child, Child A. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001739614-22-000075","document":"wf-form4_165947352645392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000173961422000075/wf-form4_165947352645392.xml","form_type":"4"}},{"id":2197263,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T20:52:22.000Z","date":"2022-08-02","kind":"gift","acquired":false,"shares":118500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of 118,500 shares of Common Stock by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust to the reporting person's children and other relatives. Of the shares gifted, 60,000 shares were gifted to the reporting person's adult children not residing in the reporting person's household, 3,400 shares were gifted to relatives not residing in the reporting person's household, and 5,100 shares were gifted to a trust for the benefit of relatives not residing in the reporting person's household, in each case to which the reporting person does not have a beneficial interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon F. Kayyem and Paige Gates-Kayyem Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":3277601,"source":{"system":"sec-edgar","filing":"0001739614-22-000075","document":"wf-form4_165947352645392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000173961422000075/wf-form4_165947352645392.xml","form_type":"4"}},{"id":2254955,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-26T20:38:28.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on May 25, 2023, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":47259,"derivative":{"exercise_price":12.57,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001739614-22-000065","document":"wf-form4_165359747904257.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000173961422000065/wf-form4_165359747904257.xml","form_type":"4"}},{"id":2255125,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-26T20:15:53.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock and has no expiration date."},{"field":"shares","element":"transactionShares","label":"F3","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."}],"balance_after":83333,"derivative":{"underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001140361-22-020784","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122020784/form4.xml","form_type":"4"}},{"id":2480500,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2021-12-08T21:30:33.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":27038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option will vest in full on March 31, 2022, subject to the reporting person's continued service on the Board through the applicable vesting date. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."}],"balance_after":27038,"derivative":{"exercise_price":5.67,"expiration_date":"2031-12-06","underlying":"Common Stock","underlying_shares":27038},"source":{"system":"sec-edgar","filing":"0001140361-21-040848","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036121040848/form4.xml","form_type":"4"}},{"id":2480499,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2021-12-08T21:30:33.000Z","date":"2021-12-06","kind":"grant","acquired":true,"shares":50368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests 40% on December 6, 2023, and the remaining 60% in 36 successive, equal monthly installments measured from December 6, 2023, generally subject to the reporting person's continued service on the Board through the applicable vesting date."}],"balance_after":50368,"derivative":{"exercise_price":5.93,"expiration_date":"2031-12-05","underlying":"Common Stock","underlying_shares":50368},"source":{"system":"sec-edgar","filing":"0001140361-21-040848","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036121040848/form4.xml","form_type":"4"}},{"id":2480498,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-12-08T21:30:33.000Z","date":"2021-12-06","kind":"grant","acquired":true,"shares":31619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units will vest in full on December 6, 2022, generally subject to the reporting person's continued service on the Issuer's board of directors (the \"Board\") through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units will vest in full on December 6, 2022, generally subject to the reporting person's continued service on the Issuer's board of directors (the \"Board\") through the applicable vesting date, and have no expiration date."}],"balance_after":31619,"derivative":{"underlying":"Common Stock","underlying_shares":31619},"source":{"system":"sec-edgar","filing":"0001140361-21-040848","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036121040848/form4.xml","form_type":"4"}},{"id":2677139,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-08T21:20:36.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"(1) Twenty-five percent (25%) of the total shares subject to the June 7, 2022, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":32259,"derivative":{"exercise_price":24.78,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001739614-21-000071","document":"wf-form4_162318722240649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366268/000173961421000071/wf-form4_162318722240649.xml","form_type":"4"}},{"id":4073772,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2018-02-06T20:24:10.000Z","date":"2018-02-02","kind":"sale","acquired":false,"shares":148,"price":5.13,"value":759.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":197622,"source":{"system":"sec-edgar","filing":"0001487371-18-000017","document":"wf-form4_151796663557707.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737118000017/wf-form4_151796663557707.xml","form_type":"4"}},{"id":4140378,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-12-06T18:20:37.000Z","date":"2017-12-04","kind":"sale","acquired":false,"shares":135,"price":4.7,"value":634.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":197770,"source":{"system":"sec-edgar","filing":"0001487371-17-000251","document":"wf-form4_151260242389809.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000251/wf-form4_151260242389809.xml","form_type":"4"}},{"id":4154277,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-11-21T18:04:00.000Z","date":"2017-11-20","kind":"sale","acquired":false,"shares":1269,"price":4.74,"value":6015.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":197905,"source":{"system":"sec-edgar","filing":"0001487371-17-000240","document":"wf-form4_151130542745787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000240/wf-form4_151130542745787.xml","form_type":"4"}},{"id":4172737,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-11-03T19:50:02.000Z","date":"2017-11-02","kind":"sale","acquired":false,"shares":135,"price":7.24,"value":977.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":199174,"source":{"system":"sec-edgar","filing":"0001487371-17-000227","document":"wf-form4_150975298830344.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000227/wf-form4_150975298830344.xml","form_type":"4"}},{"id":4216036,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-09-06T18:08:00.000Z","date":"2017-09-05","kind":"sale","acquired":false,"shares":133,"price":9.75,"value":1296.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":199309,"source":{"system":"sec-edgar","filing":"0001487371-17-000190","document":"wf-form4_150473566663948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000190/wf-form4_150473566663948.xml","form_type":"4"}},{"id":4226530,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-08-23T14:36:27.000Z","date":"2017-08-21","kind":"sale","acquired":false,"shares":1277,"price":9.45,"value":12067.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":199442,"source":{"system":"sec-edgar","filing":"0001487371-17-000181","document":"wf-form4_150351337372147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000181/wf-form4_150351337372147.xml","form_type":"4"}},{"id":4242321,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-08-04T13:25:26.000Z","date":"2017-08-02","kind":"sale","acquired":false,"shares":138,"price":10.33,"value":1425.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":200719,"source":{"system":"sec-edgar","filing":"0001487371-17-000164","document":"wf-form4_150186751312935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000164/wf-form4_150186751312935.xml","form_type":"4"}},{"id":4292917,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-06-05T16:58:46.000Z","date":"2017-06-02","kind":"sale","acquired":false,"shares":132,"price":12.89,"value":1701.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":200857,"source":{"system":"sec-edgar","filing":"0001487371-17-000138","document":"wf-form4_149669630909881.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000138/wf-form4_149669630909881.xml","form_type":"4"}},{"id":4308145,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-05-23T16:52:26.000Z","date":"2017-05-19","kind":"sale","acquired":false,"shares":1265,"price":12.89,"value":16305.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":200989,"source":{"system":"sec-edgar","filing":"0001487371-17-000115","document":"wf-form4_149557273185034.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000115/wf-form4_149557273185034.xml","form_type":"4"}},{"id":4333316,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-05-04T17:10:57.000Z","date":"2017-05-02","kind":"sale","acquired":false,"shares":133,"price":13.34,"value":1774.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":202254,"source":{"system":"sec-edgar","filing":"0001487371-17-000100","document":"wf-form4_149393224260734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000100/wf-form4_149393224260734.xml","form_type":"4"}},{"id":4392665,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-03-09T19:53:30.000Z","date":"2017-03-07","kind":"sale","acquired":false,"shares":311,"price":12.18,"value":3787.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":202387,"source":{"system":"sec-edgar","filing":"0001487371-17-000074","document":"wf-form4_148910719693921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000074/wf-form4_148910719693921.xml","form_type":"4"}},{"id":4403986,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-03-03T19:13:06.000Z","date":"2017-03-03","kind":"sale","acquired":false,"shares":131,"price":12.29,"value":1609.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":202698,"source":{"system":"sec-edgar","filing":"0001487371-17-000070","document":"wf-form4_148858637184731.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000070/wf-form4_148858637184731.xml","form_type":"4"}},{"id":4424621,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Market Stock Units","published_at":"2017-02-24T19:19:33.000Z","date":"2017-02-22","kind":"grant","acquired":true,"shares":16250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Each market stock unit (\"MSU\") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The MSUs vest in three equal installments, on each of December 31, 2017, December 31, 2018, and December 31, 2019; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The MSUs vest in three equal installments, on each of December 31, 2017, December 31, 2018, and December 31, 2019; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Each market stock unit (\"MSU\") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index."}],"balance_after":16250,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":16250},"source":{"system":"sec-edgar","filing":"0001487371-17-000050","document":"wf-form4_148798196031501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000050/wf-form4_148798196031501.xml","form_type":"4"}},{"id":4424620,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-02-24T19:19:33.000Z","date":"2017-02-22","kind":"grant","acquired":true,"shares":48750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount reported reflects restricted stock units granted to the reporting person pursuant to the Issuer's 2010 Equity Incentive Plan. The restricted stock units vest 25% on February 22, 2018 and the remaining shares subject to such award vest in 12 equal quarterly installments thereafter."}],"balance_after":202829,"source":{"system":"sec-edgar","filing":"0001487371-17-000050","document":"wf-form4_148798196031501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000050/wf-form4_148798196031501.xml","form_type":"4"}},{"id":4436055,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-02-21T20:02:55.000Z","date":"2017-02-21","kind":"sale","acquired":false,"shares":5250,"price":10.08,"value":52920.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":154079,"source":{"system":"sec-edgar","filing":"0001487371-17-000040","document":"wf-form4_148772536212075.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000040/wf-form4_148772536212075.xml","form_type":"4"}},{"id":4468653,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-02-03T17:46:13.000Z","date":"2017-02-02","kind":"sale","acquired":false,"shares":131,"price":11.58,"value":1516.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":159329,"source":{"system":"sec-edgar","filing":"0001487371-17-000022","document":"wf-form4_148616195985624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000022/wf-form4_148616195985624.xml","form_type":"4"}},{"id":4485250,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Market Stock Units","published_at":"2017-01-20T18:49:14.000Z","date":"2017-01-19","kind":"exercise","acquired":false,"shares":5927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Each MSU represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The MSUs vest in three equal installments, on each of December 31, 2016, December 31, 2017, and December 31, 2018; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The MSUs vest in three equal installments, on each of December 31, 2016, December 31, 2017, and December 31, 2018; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Each MSU represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index."}],"balance_after":11853,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5927},"source":{"system":"sec-edgar","filing":"0001487371-17-000013","document":"wf-form4_148495613948717.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000013/wf-form4_148495613948717.xml","form_type":"4"}},{"id":4485249,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Market Stock Units","published_at":"2017-01-20T18:49:14.000Z","date":"2017-01-19","kind":"exercise","acquired":false,"shares":2096,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Each MSU represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The MSUs vest in three equal installments, on each of December 31, 2015, December 31, 2016, and December 31, 2017; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The MSUs vest in three equal installments, on each of December 31, 2015, December 31, 2016, and December 31, 2017; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Each MSU represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index."}],"balance_after":3295,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2096},"source":{"system":"sec-edgar","filing":"0001487371-17-000013","document":"wf-form4_148495613948717.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000013/wf-form4_148495613948717.xml","form_type":"4"}},{"id":4485248,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-01-20T18:49:14.000Z","date":"2017-01-19","kind":"sale","acquired":false,"shares":5718,"price":12.47,"value":71303.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted MSUs."}],"balance_after":159460,"source":{"system":"sec-edgar","filing":"0001487371-17-000013","document":"wf-form4_148495613948717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000013/wf-form4_148495613948717.xml","form_type":"4"}},{"id":4485247,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-01-20T18:49:14.000Z","date":"2017-01-19","kind":"exercise","acquired":true,"shares":11535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Based on actual achievement for the one-year performance period, the recipient was issued 194.6% of the market stock units (\"MSUs\") which vested as of December 31, 2016."}],"balance_after":165178,"source":{"system":"sec-edgar","filing":"0001487371-17-000013","document":"wf-form4_148495613948717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000013/wf-form4_148495613948717.xml","form_type":"4"}},{"id":4485246,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-01-20T18:49:14.000Z","date":"2017-01-19","kind":"exercise","acquired":true,"shares":2096,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":153643,"source":{"system":"sec-edgar","filing":"0001487371-17-000013","document":"wf-form4_148495613948717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000013/wf-form4_148495613948717.xml","form_type":"4"}},{"id":4527140,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2016-12-09T17:59:34.000Z","date":"2016-12-07","kind":"sale","acquired":false,"shares":313,"price":11.08,"value":3468.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":151547,"source":{"system":"sec-edgar","filing":"0001487371-16-000398","document":"wf-form4_148132436210986.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737116000398/wf-form4_148132436210986.xml","form_type":"4"}},{"id":4531336,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2016-12-06T17:58:56.000Z","date":"2016-12-02","kind":"sale","acquired":false,"shares":132,"price":11.3,"value":1491.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":151860,"source":{"system":"sec-edgar","filing":"0001487371-16-000392","document":"wf-form4_148106512430588.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737116000392/wf-form4_148106512430588.xml","form_type":"4"}},{"id":4566583,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2016-11-04T17:37:44.000Z","date":"2016-11-02","kind":"sale","acquired":false,"shares":135,"price":10.3,"value":1390.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":151992,"source":{"system":"sec-edgar","filing":"0001487371-16-000376","document":"wf-form4_147829545168109.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737116000376/wf-form4_147829545168109.xml","form_type":"4"}},{"id":4606765,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2016-09-09T18:36:21.000Z","date":"2016-09-07","kind":"sale","acquired":false,"shares":310,"price":8.69,"value":2693.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":152127,"source":{"system":"sec-edgar","filing":"0001487371-16-000357","document":"wf-form4_147346056801196.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737116000357/wf-form4_147346056801196.xml","form_type":"4"}},{"id":4611085,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2016-09-06T18:02:48.000Z","date":"2016-09-02","kind":"sale","acquired":false,"shares":133,"price":8.62,"value":1146.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":152437,"source":{"system":"sec-edgar","filing":"0001487371-16-000347","document":"wf-form4_147319935650677.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737116000347/wf-form4_147319935650677.xml","form_type":"4"}}]}